CD19/CD22 CAR-T cell therapy
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for CD19/CD22 CAR-T cell therapy, covering 2024-12-31 to 2025-11-19. Get the full timeline:
Most recent: Clinical Trial Update: Sequential CD19/CD22 CAR-T Cell Therapy Following ASCT [Phase 2]